Adage Capital Partners’s BioAge Labs BIOA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.35M Sell
300,000
-200,000
-40% -$3.61M 0.01% 763
2026
Q1
$8.74M Sell
500,000
-550,000
-52% -$10.6M 0.01% 714
2025
Q4
$13.9M Buy
+1,050,000
New +$9.31M 0.02% 590

Other funds holding BIOA

Adage Capital Partners's BIOA Position: Q2 2026 in Review

Adage Capital Partners reduced its BioAge Labs (BIOA) stake by 40% in Q2 2026, selling an estimated $3.61M and leaving 300,000 shares worth $7.35M. The position accounts for 0.01% of the portfolio, ranked #763.

Adage Capital Partners first reported a position in BIOA in Q4 2025 and has held it in 3 quarters since. The position peaked at $13.9M in Q4 2025. 151 funds tracked by Wall St. Rank hold BIOA as of Q2 2026.

  • Adage Capital Partners held 300,000 shares of BioAge Labs worth $7.35M as of Q2 2026.
  • Adage Capital Partners sold 200,000 BioAge Labs shares in Q2 2026, an estimated $3.61M.
  • BioAge Labs made up 0.01% of Adage Capital Partners's portfolio in Q2 2026, its #763 holding.
  • Adage Capital Partners first reported a position in BioAge Labs in Q4 2025 and has held it in 3 quarters since.
  • Adage Capital Partners's BioAge Labs position peaked at $13.9M in Q4 2025.
  • 151 funds tracked by Wall St. Rank held BioAge Labs as of Q2 2026.

Based on Adage Capital Partners's 13F filing for Q2 2026, filed 14 Aug 2026.